Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits. (2020)

First Author: Faulkner V

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fmicb.2020.619427

PubMed Identifier: 33597931

Publication URI: http://europepmc.org/abstract/MED/33597931

Type: Journal Article/Review

Volume: 11

Parent Publication: Frontiers in microbiology

ISSN: 1664-302X